GSK and Pfizer to combine consumer businesses

19 December 2018 - Deborah Wilkes

Archived

GlaxoSmithKline (GSK) and Pfizer have agreed to combine their consumer healthcare businesses into a "world-leading" joint venture with combined annual sales of around GBP9.8 billion (USD12.7 billion).

Click tags below for more information on topics:

GlaxoSmithKline Pfizer

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: